Hyperliquid Strategies Stays Profitable: Strategy And Bitmine Record Losses Above $10 Billion
Crypto markets endured further pressure this week as the sell-off spread to some of the industry’s largest digital asset treasuries (DATs). As of Friday, Bitcoin (BTC) had slipped back below $60,000 for the first time since 2024, Ethereum (ETH) was trading around $1,550, and Hyperliquid (HYPE) was near $57.
While the declines weighed on the broader market, the impact has been most visible in the large treasury companies associated with BTC and ETH—specifically Strategy (MSTR) and Bitmine (BMNR).
Hyperliquid Strategies (PURR), however, has continued to post gains on an unrealized basis, highlighting how its performance still outpaces the market’s major benchmarks.
Hyperliquid Strategies Avoids The Worst With $1.2B Gains
According to Artemis data, Strategy and Bitmine are carrying significant unrealized losses of about $12.8 billion and $10.3 billion, respectively. In contrast, Hyperliquid Strategies is positioned differently.
Artemis data further indicates that Hyperliquid Strategies is the only major digital asset treasury company in the industry so far still in positive territory, with approximately $1.2 billion in unrealized gains, as seen in the chart below.
Hyperliquid Strategies is the only DAT with unrealized gains through the recent downturn. Source:
In practical terms, that means the stress seen across most crypto-linked balance sheets has not hit Hyperliquid in the same way, even as prices pulled back sharply elsewhere.
The weakness has also reached other large public holders beyond the two biggest names. Lookonchain data shows the recent retrace has extended further, with SharpLink down $1.59 billion on ETH, and Metaplanet down $1.38 billion on BTC.
The pattern is consistent: as BTC and ETH retrace, companies concentrated in those assets tend to reflect the decline in their mark-to-market or unrealized reporting.
Weekly BTC, ETH Pullback Hits MSTR, BMNR Stocks
Bitcoin’s move has been particularly notable on the weekly chart. The asset recorded a major 20% retrace on the weekly time frame, and that broader drop has filtered down to equities and crypto proxies as well.
Strategy’s stock, MSTR, fell 14% on Friday alone, trading around $115 per share. Bitmine’s stock, BMNR, also logged double-digit losses on Friday, down 12% to roughly $15.76 per share, adding to pressure on investors.
Hyperliquid’s native token, HYPE, saw its own sharp decline during the same period, dropping 14%. Even with that pullback, Hyperliquid Strategies’ PURR price showed comparatively limited movement, with only a 1.2% retrace to $8.3 for the current trading session.
Together, these snapshots underline a clear divergence: While Strategy and Bitmine reflect the drawdown of BTC and ETH in a straightforward way through large unrealized losses, Hyperliquid Strategies remains comparatively resilient, maintaining positive unrealized performance even as the market sells off.
Featured image created with OpenArt; chart from TradingView.com
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs Upgrades CoreWeave to "Buy": Market Overestimates Financing Costs and Underestimates Computing Fee Capabilities
Goldman Sachs has upgraded CoreWeave’s rating from “Neutral” to “Buy,” with a target price of $106, offering approximately 73% upside from the latest closing price of $61.39. Goldman Sachs believes the market is overly concerned about CoreWeave’s financing costs but underestimates its charging potential for computing power: asset-backed financing supported by GPU and customer contracts is not entirely tied to corporate bond yields. Additionally, annual revenue per megawatt is expected to rise from the current $10 million to $13 million, improving investment returns.

AI Credit Pressure Surfaces: CoreWeave Bonds Become the New Barometer for the US Stock Market
CoreWeave's unsecured bonds have replaced Nvidia as the market's "beta barometer" for measuring AI trades. The bonds’ yields have surged past 16% and CDS spreads have soared, highlighting the high dependence of emerging cloud computing companies on debt financing and their funding gap risks. Credit pressures are spreading from infrastructure to equity markets, and the main focus of AI trading has shifted from computing power demand to financing costs and sustainability.

GSK (GSK.US), Inovio (INO.US), and Agios (AGIO.US) cluster for review, US innovative drugs welcome FDA approval window
The FDA will intensively decide on several new drugs in the next two weeks: GSK's functional cure therapy for hepatitis B, Inovio's rare disease therapy, Agios's new drug for sickle cell disease, and Sun Pharma's application for expanded indications.

After the Philadelphia Semiconductor Index and Nasdaq plunged, Morgan Stanley called to "get ready to increase positions"
Michael Wilson from Morgan Stanley stated that as the significant correction trajectory in most stock markets over the past few months is about to end, investors should be prepared to increase the risk exposure in their portfolios.
